Related Experiment Video
Updated: Jul 16, 2025
Modeling Brain Metastasis Via Tail-Vein Injection of Inflammatory Breast Cancer Cells
Published on: February 4, 2021
SRRM4-mediated REST to REST4 dysregulation promotes tumor growth and neural adaptation in breast cancer leading to
Krutika Deshpande1,2, Vahan Martirosian1,3, Brooke N Nakamura4,3
1Department of Neurological Surgery, Keck School of Medicine, University of Southern California, Los Angeles, California, USA.
Background:
Effective control of brain metastasis remains an urgent clinical need due a limited understanding of the mechanisms driving it. Although the gain of neuro-adaptive attributes in breast-to-brain metastases (BBMs) has been described, the mechanisms that govern this neural acclimation and the resulting brain metastasis competency are poorly understood. Herein, we define the role of neural-specific splicing factor Serine/Arginine Repetitive Matrix Protein 4 (SRRM4) in regulating microenvironmental adaptation and brain metastasis colonization in breast cancer cells.
Methods:
Utilizing pure neuronal cultures and brain-naive and patient-derived BM tumor cells, along with in vivo tumor modeling, we surveyed the early induction of mediators of neural acclimation in tumor cells.
Results:
When SRRM4 is overexpressed in systemic breast cancer cells, there is enhanced BBM leading to poorer overall survival in vivo. Concomitantly, SRRM4 knockdown expression does not provide any advantage in central nervous system metastasis. In addition, reducing SRRM4 expression in breast cancer cells slows down proliferation and increases resistance to chemotherapy. Conversely, when SRRM4/REST4 levels are elevated, tumor cell growth is maintained even in nutrient-deprived conditions. In neuronal coculture, decreasing SRRM4 expression in breast cancer cells impairs their ability to adapt to the brain microenvironment, while increasing SRRM4/RE-1 Silencing Transcription Factor (REST4) levels leads to greater expression of neurotransmitter and synaptic signaling mediators and a significant colonization advantage.
Conclusions:
Collectively, our findings identify SRRM4 as a regulator of brain metastasis colonization, and a potential therapeutic target in breast cancer.
Insights
Serine/Arginine Repetitive Matrix Protein 4 (SRRM4) drives breast cancer brain metastasis by promoting neural adaptation. Targeting SRRM4 may offer a new therapeutic strategy for controlling brain metastases and improving patient survival.
Area of Science:
- Oncology
- Neuroscience
- Cancer Biology
Background:
- Effective control of brain metastasis is a significant clinical challenge due to poorly understood underlying mechanisms.
- While neuro-adaptive traits in breast-to-brain metastases (BBMs) are recognized, the specific drivers of neural acclimation and brain colonization competency remain unclear.
- This study investigates the role of the neural-specific splicing factor Serine/Arginine Repetitive Matrix Protein 4 (SRRM4) in breast cancer's adaptation to the brain microenvironment.
Purpose of the Study:
- To define the role of SRRM4 in regulating microenvironmental adaptation in breast cancer cells.
- To elucidate the mechanisms by which SRRM4 influences brain metastasis colonization.
- To evaluate SRRM4 as a potential therapeutic target for breast cancer brain metastasis.
Main Methods:
- Utilized pure neuronal cultures and both brain-naive and patient-derived breast-to-brain metastasis (BBM) tumor cells.
- Employed in vivo tumor modeling to survey early induction of neural acclimation mediators in tumor cells.
- Assessed the impact of SRRM4 overexpression and knockdown on tumor cell behavior, proliferation, chemotherapy resistance, and colonization in a brain microenvironment model.
Main Results:
- Overexpression of SRRM4 in breast cancer cells enhanced BBM and correlated with poorer overall survival in vivo.
- SRRM4 knockdown slowed breast cancer cell proliferation and increased chemotherapy resistance.
- Elevated SRRM4/RE-1 Silencing Transcription Factor (REST4) levels promoted tumor cell growth in nutrient-deprived conditions and enhanced adaptation to the brain microenvironment, including increased expression of neurotransmitter and synaptic signaling mediators.
Conclusions:
- SRRM4 acts as a key regulator of brain metastasis colonization in breast cancer.
- SRRM4 influences breast cancer cell adaptation to the brain microenvironment and promotes colonization.
- SRRM4 represents a potential therapeutic target for managing breast cancer brain metastasis.
Related Concept Videos
03:03mTOR Signaling and Cancer Progression
The mTOR pathway or the...
02:23Abnormal Proliferation